96960 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-3
HUMANIZED IMMUNODEFICIENT MOUSE MODELS
#2Genetically Modified Mice and Engraftment
#3METHODS AND MODELS FOR ASSESSING EFFICACY OF IMMUNOTHERAPIES
#4Non-Signaling Chimeric Antigen Receptor Gamma Delta T-Cells
#5THERAPEUTIC CYTOKINES AND METHODS
#6VECTORS, GENETICALLY MODIFIED CELLS, AND GENETICALLY MODIFIED NON-HUMAN ANIMALS COMPRISING THE SAME
#7CHIMERIC ANTIGEN RECEPTOR MODIFIED REGULATORY T CELLS FOR TREATING CANCER
#8APPLICATION OF GENETICALLY MODIFIED OLIGODENDROCYTE PROGENITOR CELLS IN MULTIPLE SCLEROSIS
#9BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#10GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO
#11TRANSGENIC MOUSE MODEL EXPRESSING HUMAN HLA-A201 RESTRICTION GENE
#12REGENERATIVE CAR-T CELLS
#13ENGINEERED OPTIMIZED CYTOKINE COMPOSITIONS
#14Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#15Genetically Modified Mice and Engraftment
#16LEUCINE ZIPPER-BASED COMPOSITIONS AND METHODS OF USE
#17Engineered Optimized Cytokine Compositions
#18Genetically modified non-human animals and methods of use thereof
#19Peptide for suppressing osteoclast differentiation and use thereof
#20Genetically modified non-human animals expressing human EPO
#21Compositions and methods for expansion of embryonic hematopoietic stem cells
#22Fusion polypeptides comprising one or more inclusion body tags, methods and uses
#23METHOD FOR THE PREPARATION AND PROLONGED STORAGE OF GROWTH FACTORS AND CYTOKINES OBTAINED FROM PLATELET RICH PLASMA
#24Genetically modified mice and engraftment
#25CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF
#26Methods for inhibiting hematopoietic tumor cells with diphtheria tokin-interleukin-3 conjugates
#27Compositions and methods for expansion of embryonic hematopoietic stem cells
#28Peptide for suppressing osteoclast differentiation and use thereof
#29Genetically modified non-human animals and methods of use thereof
#30Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#31Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11
#32Genetically modified mice and engraftment
#33Genetically modified non-human animals and methods of use thereof
#34Peptide for suppressing osteoclast differentiation and use thereof
#35Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#36Compositions and methods for expansion of embryonic hematopoietic stem cells
#37Genetically modified non-human animals expressing human EPO
#38Interleukin-3 Polypeptide Conjugates and Their Uses
#39Modified SAK gene for the production of recombinant proteins
#40DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#41Genetically modified non-human animals and methods of use thereof
#42Genetically modified mice and engraftment
#43Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#44Modified SAK gene for the production of recombinant proteins
#45Genetically modified mice and engraftment
#46Genetically modified mice and engraftment
#47Recombinant Human Albumin-Granulocyte Macrophage Colony Stimulating Factor Fusion Protein With Long-Lasting Biological Effects
#48Cysteine variants of interferon gamma
#49Genetically modified mice and engraftment
#50RETRO-INVERSO PEPTIDES DERIVED FROM INTERLEUKIN-3
#51Integrated cytokine production system
#52Recombinant human albumin-interleukin-11 fusion protein with long-lasting biological effects
#53Long Acting Human Interferon Analogs
#54Methods for treating acute myeloid leukemia with diphtheria toxin-interleukin-3 conjugates
#55PARAMETER SELECTED GM-CSF, IL-3, IL-4, IL-5 AND CHIMERAS THEREOF FOR THERAPEUTIC AND DIAGNOSTIC PURPOSES
#56DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#57Long acting human interferon analogs
#58Cysteine variants of interferon gamma
#59Cysteine variants of interferon-gamma
#60Methods for treating myelodysplastic syndrome with a human interleukin-3-diphtheria toxin conjugate
#61Recombinant human albumin-erythropoietin fusion proteins with long-lasting biological effects
#62Multi-functional chimeric hematopoietic receptor agonists
#63Methods of using retro-inverso peptides derived from interleukin-3
#64Enhanced secretion of a polypeptide by a microorganism
#65Cloning and sequencing of allergens of dermatophagoides (house dust mite)
#66Interleukin-3 (IL-3) multiple mutation polypeptides
#67Cysteine substitution variants of beta interferon
#68COOH-terminally added cysteine variant of the beta interferon
#69Enhanced secretion of a polypeptide by a microorganism
#70Enhanced secretion of a polypeptide by a microorganism
#71Enhanced secretion of a polypeptide by a microorganism
#72Enhanced secretion of a polypeptide by a microorganism
#73Cysteine variants of erythropoietin
#74Cysteine variants of erythropoietin
#75Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins